Eur J Obstet Gynecol Reprod Biol. 2014 Oct;181:205-9. doi: 10.1016/j.ejogrb.2014.07.011. Epub 2014 Aug 10.
Ulug P1, Oner G2.
Author information 1Department of Obstetrics and Gynecology, Erzincan University, Turkey.2Department of Obstetrics and Gynecology, Mugla Sitki Kocman University, Turkey. Electronic address: email@example.com.
Eur J Obstet Gynecol Reprod Biol
AbstractOBJECTIVE: To evaluate the effects of single, multiple dose methotrexate (MTX) administration and salpingectomy on ovarian reserve in a rat model.STUDY DESIGN: In this prospective controlled experimental study, forty female Wistar-albino rats were randomly divided into four groups; healthy control group (group 1), one month after single dose (50mg/m(2)) MTX administration group (group 2), multiple (1mg/kg, 1, 3, 5, 7 days) dose MTX administration group (group 3), and unilateral salpingectomy applied group (group 4). Ovarian reserves were assessed with anti-Müllerian hormone (AMH) and ovarian follicles including primordial, primary, secondary, tertiary and total follicle counts.SETTING: Kobay and Duzen experimental research laboratory.RESULTS: Serum AMH levels decreased significantly in the single and multiple dose MTX administration group and salpingectomy group compared with control group. Primordial follicle counts were comparable between single dose MTX group and control group whereas all type of follicle counts in single and multiple dose MTX and salpingectomy group were significantly reduced compared with control. The least affected ovarian reserve in the treatment groups was single dose MTX group.CONCLUSIONS: Ovarian reserve markers including follicle counts and AMH levels were decreased after single, multiple dose MTX administration, and salpingectomy. Single dose MTX was the least detrimental method on ovarian reserve for the treatment of ectopic pregnancy.Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Full Text Source: Elsevier Science
PMID:25171264 | http://www.ncbi.nlm.nih.gov/pubmed/25171264